egafur，Gimeracil and Oteracil Potassium Capsules.

Effects and efficacy:
Tegafur has anti-tumor effects and is mainly used to treat unresectable locally advanced or metastatic gastric cancer.
Usage and dosage:
This tablet (capsule) is used in combination with cisplatin to treat patients with unresectable locally advanced or metastatic gastric cancer. The recommended dosage is: 40 mg each time for patients with a body surface area of ​​less than 1.25 m2, 50 mg each time for patients with a body surface area between 1.25 and 1.5 m2, and 60 mg each time for patients with a body surface area of ​​more than 1.5 m2. Twice a day, 28 consecutive days, 14 days of rest as a treatment cycle, intravenous infusion of cisplatin 60 mg/m2 on the 8th day of administration. Continue to use the drug until the condition worsens or cannot be tolerated. According to the patient’s condition, under the guidance of a doctor, the dosage of each dose is increased or decreased in the order of four dose levels of 40 mg, 50 mg, 60 mg, and 75 mg. If there are no safety issues such as abnormalities in blood routine, liver and kidney function, and gastrointestinal symptoms caused by this drug, and the physician determines that it is necessary to increase the dose, then one dose level can be increased in the above order, with an upper limit of 75 mg/time. If a dose reduction is required, it should be reduced in descending order according to the dose level, with a lower limit of 40 mg/time. The same drugs produced by different manufacturers may have inconsistent instructions. If you find inconsistencies in the instructions before taking the drug, please consult a doctor or pharmacist in time.
Drug contraindications:
Allergic to this product is prohibited. It is prohibited during lactation. It is prohibited during pregnancy. It should be used with caution in children. It should be used with caution in liver and kidney dysfunction.
Related dosage forms:
Tablets, capsules